On its second bid day, investors are responding favourably to Akums Drugs and Pharmaceuticals’ initial public offering, which comes as the Nity 50 is about to reach 25,000 levels in a bull market. Akums Drugs and Pharmaceuticals IPO subscription status is 4.43 times, according to BSE data. The price band […]
anchor investors
Investor response to Emcure Pharmaceuticals IPO on the second bidding day was overwhelmingly positive, with the market as a whole being robust. The offering has flowed quite well thanks to the enthusiasm shown by non-institutional investors, individual investors, and qualified institutional buyers. The Pune-based company Emcure Pharmaceuticals is involved in […]
A fresh issue of ₹1,000 crore and an offer-for-sale (OFS) of ₹500 crore worth of equity shares by the promoters and other investors make up the ₹1,500 crore Allied Blenders and Distillers IPO. Also Read: Allied Blenders and Distillers IPO: Price band fixed at ₹267-281 apiece; check issue details, key […]
Major investors that have subscribed to ixigo IPO’s anchor book include Nomura, Morgan Stanley, 3P India Equity Fund, HDFC MF, Motilal Oswal MF, the Government of Singapore, and Tata Investment Corporation. “The IPO Committee of the company at its meeting held on June 07, 2024, in consultation with Axis Capital […]